Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial

Toshiyuki Sawa; Takashi Yana; Minoru Takada; Takahiko Sugiura; Shinzoh Kudoh; Tadashi Kamei; Takeshi Isobe; Hidehiko Yamamoto; Soichiro Yokota; Nobuyuki Katakami; Yuji Tohda; Akira Kawakami; Yoichi Nakanishi; Yutaka Ariyoshi

首页> 外文期刊>Investigational New Drugs >Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial

【24h】

Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial

机译：9氨基蒽环类药物氨柔比星在晚期非小细胞肺癌患者中的多中心II期研究（研究1）：西日本胸腔肿瘤小组（WJTOG）试验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Purpose: Amrubicin is a novel 9-aminoanthracycline. This multicenter phase II study was conducted to evaluate the efficacy and safety of amrubicin in patients with non-small-cell lung cancer (NSCLC).

机译：目的：氨柔比星是一种新型的9-氨基蒽环类药物。这项多中心II期研究旨在评估氨柔比星在非小细胞肺癌（NSCLC）患者中的疗效和安全性。

著录项

来源
《Investigational New Drugs》 |2006年第2期|151-158|共8页
作者
Toshiyuki Sawa; Takashi Yana; Minoru Takada; Takahiko Sugiura; Shinzoh Kudoh; Tadashi Kamei; Takeshi Isobe; Hidehiko Yamamoto; Soichiro Yokota; Nobuyuki Katakami; Yuji Tohda; Akira Kawakami; Yoichi Nakanishi; Yutaka Ariyoshi;
展开▼
作者单位

Division of Respiratory Medicine Gifu Municipal Hospital;

Department of Internal Medicine Osaka Prefectural Habikino Hospital;

Department of Internal Medicine Osaka Prefectural Habikino Hospital;

Department of Internal Medicine Aichi Cancer Center;

Department of Respiratory Medicine Osaka City University Hospital;

Department of Internal Medicine Kagawa Prefectural Central Hospital;

Second Department of Internal Medicine Hiroshima University Faculty of Medicine;

Department of Respiratory Medicine Aso Iizuka Hospital;

Department of Internal Medicine National Toneyama Hospital for Chest Diseases;

Division of Pulmonary Medicine Kobe City General Hospital;

Department of Medical Oncology Kinki University School of Medicine;

Department of Respiratory Medicine National Hospital Organization Kyoto Medical Center;

Department of Respiratory Medicine Graduate School of Medical Sciences Kyushu University;

Department of Internal Medicine Prefectural Aichi Hospital;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Amrubicin; Anthracycline; Non-small cell lung cancer; Phase II study;

机译：氨柔比星;蒽环类;非小细胞肺癌;第二阶段研究;

相似文献

外文文献
中文文献
专利

1. Phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group (WJTOG) study [J] . Koji Takeda, Nobuhide Takifuji, Shunichi Negoro, Investigational New Drugs . 2007,第4期

机译：晚期非小细胞肺癌患者氨柔比星9-氨基蒽环类药物的II期研究：西日本胸腔肿瘤小组（WJTOG）的研究
2. Phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group (WJTOG) study. [J] . Takeda K, Takifuji N, Negoro S, Investigational new drugs. . 2007,第4期

机译：晚期非小细胞肺癌患者氨柔比星9-氨基蒽环类药物的II期研究：西日本胸腔肿瘤小组（WJTOG）的研究。
3. Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904). [J] . Kudoh S, Takeda K, Nakagawa K, Journal of Clinical Oncology . 2006,第22期

机译：多西他赛与长春瑞滨在老年晚期非小细胞肺癌患者中进行的III期研究：西日本胸腔肿瘤小组试验的结果（WJTOG 9904）。
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. The effectiveness of chemoradiation for stage III non-small-cell lung cancer patients at the Kingston Regional Cancer Center (Ontario). [D] . Sinclair, Suzanne Marie. 2003

机译：金斯敦地区癌症中心（安大略省）对III期非小细胞肺癌患者进行化学放射治疗的有效性。
6. Randomised phase II study of docetaxel/cisplatin vs docetaxel/irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803) [O] . N Yamamoto, M Fukuoka, S-I Negoro, 2004

机译：多西他赛/顺铂与多西他赛/伊立替康在晚期非小细胞肺癌中的随机II期研究：西日本胸腔肿瘤小组研究（WJTOG9803）
7. Phase II Trial of Amrubicin for Second-Line Treatment of Advanced Non-small Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG0401) [O] . Kaneda Hiroyasu, Okamoto Isamu, Hayashi Hidetoshi, 2010

机译：氨柔比星二线治疗晚期非小细胞肺癌的二期试验：西日本胸腔肿瘤小组试验的结果（WJTOG0401）

Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅